ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of the residual tumor, detection of the disease cour...

Full description

Bibliographic Details
Main Authors: T. A. Мitina, A. K. Golenkov, A. Yu. Baryshnikov, A. V. Karaulov, E. V. Trifonova, Yu. B. Chernykh, E. V. Katayeva, T. D. Lutskaya, L. L. Vysotskaya, G. A. Dudina, S. G. Zacharov, A. M. Fomin, N. V. Lyubimova, I. N. Kogarko
Format: Article
Language:Russian
Published: MONIKI 2016-02-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
multiple myeloma
free light chains
bortezomib
Online Access:https://www.almclinmed.ru/jour/article/view/28

Internet

https://www.almclinmed.ru/jour/article/view/28

Similar Items